JPEU yields 3.78% · MRK yields 3.25%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, JPEU + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JPEU + MRK for your $10,000?
The investment seeks investment results that closely correspond, before fees and expenses, to the performance of the JP Morgan Diversified Factor Europe Equity Index. The fund will invest at least 80% of its assets in securities included in the underlying index. The underlying index is comprised of equity securities across developed Europe selected to represent a diversified set of factor characteristics: value, momentum, and quality. The fund may invest in depositary receipts representing securities included in the underlying index.
Full JPEU Calculator →Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.